Cargando…
Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives
Autores principales: | O’Dwyer, Maire, Watkins, Lance, McCallion, Philip, McCarron, Mary, Henman, Martin, Shankar, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361510/ https://www.ncbi.nlm.nih.gov/pubmed/34394909 http://dx.doi.org/10.1177/20420986211025157 |
Ejemplares similares
-
The adverse effects of long-term exposure to anticholinergics among people with intellectual disabilities: a scoping review
por: Al Shuhaimi, Lamya, et al.
Publicado: (2022) -
The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study
por: AlMutairi, Hadiah, et al.
Publicado: (2018) -
Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study
por: O'Dwyer, Máire, et al.
Publicado: (2016) -
Medication and supplement use in older people with and without intellectual disability: An observational, cross-sectional study
por: Peklar, Jure, et al.
Publicado: (2017) -
Association of Drug Burden Index with grip strength, timed up and go and Barthel index activities of daily living in older adults with intellectual disabilities: an observational cross-sectional study
por: O’Connell, Juliette, et al.
Publicado: (2019)